NCT04720209View on ClinicalTrials.gov

Taking AIM at Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 13, 2021

Primary Completion Date

August 31, 2026

Study Completion Date

September 15, 2026

Conditions
Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage III
Interventions
OTHER

CARE

CARE is a 16-week, supervised, periodized AE and RE program performed in a circuit fashion 3 days/week on-site

OTHER

TARE

TARE is a 16- week, supervised AE and RE program consisting of three sessions per week on-site

OTHER

Home-Based Stretching

This group will perform a home-based program of the same stretches utilized in the CARE and TARE groups.

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Dana-Farber Cancer Institute

OTHER